New eczema drug from Eli Lilly receives FDA approval for children and adults - USA Today
FDA approves Eli Lilly's injectable eczema drug Ebglyss for adults and children 12+, targeting IL-13 protein. Available in weeks, it offers a monthly dosing option compared to competitors like Dupixent.
Reference News
New eczema drug from Eli Lilly receives FDA approval for children and adults - USA Today
FDA approves Eli Lilly's injectable eczema drug Ebglyss for adults and children 12+, targeting IL-13 protein. Available in weeks, it offers a monthly dosing option compared to competitors like Dupixent.